Fidelity Investments’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
Fidelity Investments's RXST Position: Q2 2026 in Review
Fidelity Investments increased its RxSight (RXST) stake by 209% in Q2 2026, buying an estimated $118K and bringing the position to 28,921 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #3828.
Fidelity Investments first reported a position in RXST in Q1 2022 and has held it in 18 quarters since. The position peaked at $75.5M in Q2 2024. 150 funds tracked by Wall St. Rank hold RXST as of Q2 2026.
- Fidelity Investments held 28,921 shares of RxSight worth $139K as of Q2 2026.
- Fidelity Investments bought 19,574 RxSight shares in Q2 2026, an estimated $118K.
- RxSight made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3828 holding.
- Fidelity Investments first reported a position in RxSight in Q1 2022 and has held it in 18 quarters since.
- Fidelity Investments's RxSight position peaked at $75.5M in Q2 2024.
- 150 funds tracked by Wall St. Rank held RxSight as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.